Editor’s Note
**Editor’s Note:** This article explores a notable shift in the Korean beauty landscape, moving from topical skincare to regenerative medicine. We examine the rise of treatments like Re2O, which utilize biological materials to support the skin’s natural structure, signaling a new direction for aesthetic medicine.
For years, Korean beauty was associated with skincare products such as creams, serums and face masks. Today, the focus is shifting beyond cosmetics toward regenerative medicine. One example is Re2O, a treatment now being offered in clinics in Seoul’s Gangnam district. Instead of simply filling wrinkles, it aims to support the skin’s natural structure using biological materials derived from donated human tissue.
The treatment does not inject living human skin into the face. Instead, donated skin tissue is processed in a laboratory. All living cells are removed, leaving behind a natural biological framework known as the Extracellular Matrix (ECM). This purified material is then injected into the face, where it may help support tissue repair and improve skin structure. Doctors say the treatment may be useful for people who have lost facial volume due to ageing or rapid weight loss.
The treatment costs around ₹40,000 to ₹50,000 per session, yet demand continues to grow. Some clinics reportedly have waiting lists. South Korea is not alone. In the United States, a similar regenerative product called Renuva, made from donated human fat tissue, is already available for cosmetic use. These developments suggest that regenerative medicine is gradually becoming part of the global beauty industry.
The science behind the treatment is only one part of the story. The larger debate is about how donated human tissue should be used. Traditionally, donated skin has been reserved for patients with severe burns, reconstructive surgery, and other critical medical conditions. Some experts question whether such valuable biological material should also be used for cosmetic procedures. What happens if demand for beauty treatments begins to compete with the needs of patients requiring life-changing medical care? This question has already reached lawmakers in South Korea. While critics on social media have described the treatment as using “corpse fluid,” companies behind the technology argue that the material comes only from legally donated tissue with informed consent and is processed under strict medical standards.
Reading about this technology brings to mind Patrick Süskind’s famous novel Perfume. In the novel, the search for perfect beauty becomes an obsession that leads to horrifying crimes. The story is fictional, while the medical treatment in South Korea is entirely legal and based on donated human tissue. The comparison is not about the science. It is about the question both stories raise. How far is humanity willing to go in the pursuit of beauty?
At present, donated human skin in India is used mainly for medical purposes, including burn treatment and reconstructive surgery. Cosmetic procedures similar to those now being offered in South Korea are not part of routine clinical practice in India. Medical experts also stress that any new regenerative technology should be supported by strong scientific evidence, clear regulations and ethical oversight before becoming widely available.
This is not simply a story about skincare. It is a story about how advances in regenerative medicine are changing the meaning of tissue donation. For decades, donated human tissue has been used to save lives and restore bodies damaged by injury or disease. Now, it is beginning to play a role in preserving youth and appearance. The science may be new. But the question it raises is timeless. Where should medicine draw the line between healing people and enhancing beauty?